4.1 Purpose and Scope
This policy ensures readers can evaluate potential influences on research and editorial decisions. It applies to authors, editors, guest editors, reviewers, and publisher staff involved in assessment or decision-making. It covers financial and non-financial interests, funder roles, and third-party services.
4.2 Definitions
- Conflict of Interest (COI): Any interest that could reasonably be perceived to influence professional judgment. A COI is not misconduct; it is a condition to be disclosed and managed.
- Financial interests: Employment, consultancies, honoraria, speaker fees, travel support, research grants, equity or stock options, patents, royalties, paid expert testimony, paid writing or editing.
- Non-financial interests: Personal, academic, or ideological relationships; competitive advantage; leadership roles; editorships; advisory memberships; close collaborations within the past three years.
- Funder: Any entity providing money, materials, data, access, or in-kind support, including agencies, charities, companies, and consortia.
- Third-party services: Professional or commercial assistance (e.g., statistical consulting, language editing, data collection firms, CROs).
4.3 General Principles
- Full disclosure: All relevant interests must be declared at submission and updated if circumstances change.
- Transparency of funding and roles: Manuscripts must state who funded what and what role the funder played in design, data collection, analysis, interpretation, writing, and the decision to submit.
- Independence: Analytic and editorial decisions must be independent of funders, sponsors, advertisers, and institutional stakeholders.
- Documentation: Disclosures are recorded in the editorial system and published with the article when applicable.
- Proportional management: Declared interests are managed through recusal, additional oversight, or independent replication as needed.
4.4 Responsibilities - Authors
- At submission: Provide a comprehensive COI statement and a Funding statement for all named authors.
- During review: Update disclosures if new relationships arise.
- At publication: Agree that the final, plain-language COI and Funding statements will appear in the article.
- Record-keeping: Retain supporting documentation (e.g., grant award letters, consultancy contracts) for audit on reasonable request.
4.4.1 Author COI Statement (published)
- A COI statement must appear in the article. Examples of acceptable wording:
- No conflicts: “The authors declare no competing interests.”
- With conflicts (financial and non-financial):
- “Author A has received consulting fees from a diagnostics company unrelated to this work. Author B serves on the advisory board of a professional society. Author C reports research funding to their institution from a national research agency for a different project. All other authors declare no competing interests.”
4.4.2 Funding Statement (published)
- Role-free support:
- “This work was supported by external funding. The funder had no role in study design; data collection, analysis, or interpretation; writing of the report; or the decision to submit.”
- Role-involved support:
- “This work was supported by external funding. Representatives of the funder contributed to [design/analysis/interpretation/writing]. Final responsibility for the decision to submit rested with the authors.”
4.4.3 Data/Materials Access
- If the funder restricts data or materials, the manuscript must state the restriction and justify it. Where possible, deposit data/code in a trusted repository and specify the access route.
4.5 Responsibilities - Editors and Publisher Staff
- Annual disclosure: Editors and relevant staff file annual COI declarations and update them promptly upon change.
- Recusal: An editor with a relevant COI (financial ties, close collaboration within the last three years, same department, family or romantic relationship, strong personal dispute) must not handle the manuscript; a conflict-free editor is assigned.
- Editor-authored content: Submissions by editors are processed through an independent editorial route with firewalled access and documented decision trails.
- Sponsored content and supplements: Sponsor roles are disclosed; sponsors have no decision authority; peer review remains standard.
4.6 Responsibilities - Reviewers
- Before accepting an invitation: Reviewers disclose any COI that could reasonably be perceived as influencing their report. Examples include recent collaboration, direct competition, employment ties, or financial relationships with companies whose products or interests are central to the manuscript.
- If uncertain: Reviewers describe the situation to the editor; the editor decides whether to proceed or reassign.
- During review: Reviewers must not use confidential information for personal advantage or share it with third parties.
4.7 Time Windows for COI
- Default window: Interests within the past three years,
- current, and known future commitments (e.g., pending consultancies).
- Longer windows: Patent applications, equity holdings, and continuing royalties are relevant beyond three years and must be declared.
4.8 Prohibited or Restricted Arrangements
- Ghost management: Undisclosed participation by sponsors, professional writers, or analysis firms is prohibited.
- Publication control: Agreements that give funders the right to veto, delay, or suppress publication are not permitted. Contracts must allow authors to publish accurate results without undue restriction.
- Conditional authorship: Paid or brokered authorship is not allowed.
4.9 Managing Declared Conflicts (Actions)
Management actions depend on the risk of influence and may include:
- Editorial recusal and reassignment.
- Independent statistical review or additional peer reviewers.
- Transparency notes in the article describing how potential bias was mitigated.
- Editorial expression of concern if issues arise post-publication while investigation proceeds.
- Correction or retraction where the scholarly record requires it.
4.10 Third-Party Services and Industry Collaboration
- When professional services contribute substantially (e.g., data collection firms, CROs, medical writers, statisticians), their identity, funding source, and roles must be disclosed in the manuscript (Acknowledgments or Methods).
- Medical writing assistance must be acknowledged by name; undisclosed writing support is unacceptable.
- For industry-funded studies, authors must state who had data access, who performed analyses, and who controlled the decision to submit.
4.11 Public Disclosure and Indexing
- Published articles carry COI and Funding statements in a consistent location (often immediately before the References).
- Metadata includes COI and funder information to facilitate indexing and public discovery.
4.12 Investigating Undeclared or Disputed COI
- Trigger: Concerns may be raised by readers, reviewers, editors, or institutions.
- Process: Fact-finding, author contact, request for documents, and an assessment of materiality.
- Outcomes: No action; publication of an addendum or correction with full disclosure; expression of concern; or retraction for material nondisclosure.
- Notification: Where appropriate, relevant institutions or funders are notified.
4.13 Sanctions for Non-Disclosure or Misrepresentation
- Possible sanctions include submission bans for a defined period, withdrawal of under-review manuscripts, and retraction of published articles when the record is compromised.
4.14 Accessibility and Plain-Language Clarity
- All COI and Funding statements are written in clear, plain English understandable to non-specialists. Jargon is avoided; acronyms are expanded at first mention.
4.15 Records, Audits, and Retention
- COI and Funding forms are stored securely for a defined retention period consistent with legal and institutional requirements.
- The publisher may conduct periodic audits to verify compliance.
- A version history for this policy is maintained with public “last updated” dates.
4.16 Consent for Named Acknowledgments
- Individuals named in Acknowledgments must consent to being named. If consent cannot be obtained, describe contributions without identifying the person.
4.17 Example: Combined Disclosure Section (for publication)
- Competing interests: “The authors declare no competing interests” or a plain-language list of relevant interests, as shown in 4.4.1.
- Funding: A concise description of sources and roles, as shown in 4.4.2.
- Data access: A one-sentence note stating who had access to the data and who verified the data.
4.18 Continuous Improvement
- This policy is periodically reviewed to align with evolving best practices in research integrity and transparency. Substantive changes are communicated on the policy page and applied prospectively.